https://doi.org/10.4081/aiua.2026.15169
Renal suppurative infections: analysis of a series of 32 cases
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 1 July 2026
Introduction: Renal suppurative infections (RSIs), including pyonephrosis, renal abscess, and perinephric abscess, are rare but potentially life-threatening conditions. This study aimed to evaluate the epidemiological, diagnostic, therapeutic, and outcome aspects of RSIs.
Materials and methods: We conducted a retrospective descriptive study of patients admitted for renal suppurative infections in the urology department of CHU Yalgado Ouédraogo between November 2021 and December 2023. Epidemiological, clinical, biological, radiological, and therapeutic data were analyzed.
Results: Among 1.377 admitted patients, 32 cases of RSIs were identified (hospital prevalence: 2.32%). The mean age was 37.48 ± 15.68 years, with a female predominance (sex ratio 1.4). Fever-associated flank pain was the main presenting symptom (84.38%). Obstructive uropathy, particularly urolithiasis and schistosomiasis-related ureteral lesions, was the main etiological factor. Pyonephrosis was the most frequent diagnosis (68.75%). All patients underwent ultrasonography, complemented by computed tomography in 78.12% of cases. Biological findings showed anemia, leukocytosis, and impaired renal function in a substantial proportion of patients. Escherichia coli was the most frequently isolated pathogen. Management combined broadspectrum antibiotic therapy and systematic percutaneous drainage. Secondary etiological surgery was performed in 56.06% of cases. The mean hospital stay was 30.13 ± 26.83 days. The mortality rate was 12.9%, mainly associated with underlying malignancy.
Conclusions: RSIs remain severe infections requiring prompt diagnosis and multidisciplinary management. Early antibiotic therapy combined with effective drainage improves outcomes; however, prognosis is strongly influenced by underlying comorbidities. Optimizing the management of obstructive uropathies and associated conditions is essential to reduce morbidity and mortality.
Downloads
1. Lam H, Tan C, Tan E, et al. Acute suppurative renal infections. Singapore Medical Journal. 1986; 27:128-34.
2. Tamburrini S, Lugarà M, Iannuzzi M, et al. Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review. Diagnostics (Basel). 2021; 11.
3. Ndour N, Ondo C, Sarr A, et al. Pyonephrosis: epidemiological, clinical, and therapeutic aspects at Aristide Le Dantec University Hospital Centre (Dakar). African Urology. 2024; 4:7-11.
4. Watson RA, Esposito M, Richter F, et al. Percutaneous nephrostomy as adjunct management in advanced upper urinary tract infection. Urology. 1999; 54:234-9.
5. Anderson KA, McAninch JW. Renal abscesses: classification and review of 40 cases. Urology. 1980; 16:333-8.
6. Fowler JE, Jr., Perkins T. Presentation, diagnosis and treatment of renal abscesses: 1972-1988. J Urol. 1994; 151:847-51.
7. Meng MV, Mario LA, McAninch JW. Current treatment and outcomes of perinephric abscesses. J Urol. 2002; 168:1337-40.
8. Saiki J, Vaziri ND, Barton C. Perinephric and intranephric abscesses: a review of the literature. West J Med. 1982; 136:95-102.
9. Multescu R, Stanescu F, Geavlete B. Percutaneous Approach of Renal and Perirenal Suppurations. Percutaneous Surgery of the Upper Urinary Tract: Elsevier; 2016. p. 179-82.
10. Gardiner RA, Gwynne RA, Roberts SA. Perinephric abscess. BJU Int. 2011; 107(Suppl 3):20-3.
11. Lee BE, Seol HY, Kim TK, et al. Recent clinical overview of renal and perirenal abscesses in 56 consecutive cases. Korean J Intern Med. 2008; 23:140-8.
12. Okafor CN, Onyeaso EE. Perinephric Abscess. 2025.
13. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001; 183 Suppl 1:S1-4.
14. Muhammad A, Onwuasoanya U, Mohammad Y, et al. Presentation, risk factors, microbiological pattern and management of urosepsis in a tertiary hospital in Nigeria. Journal of Medical and Basic Scientific Research. 2021; 1:1-7.
15. Ondongo AA, Ondziel AO, Banga RM, et al. Prise en Charge de la Pyonéphrose au CHU de Brazzaville. Health Sciences and Disease 2021; 22:90-95
16. Liu XQ, Wang CC, Liu YB, Liu K. Renal and perinephric abscesses in West China Hospital: 10-year retrospective-descriptive study. World J Nephrol. 2016; 5:108-14.
17. Coelho RF, Schneider-Monteiro ED, Mesquita JL, et al. Renal and perinephric abscesses: analysis of 65 consecutive cases. World J Surg. 2007; 31:431-6.
18. Diallo Y, Kouka S, Kane R, et al. Pyonéphrose: Aspects cliniques et thérapeutiques à propos de 19 cas. Diabète. 2016; 2:5.
19. Kumar LP, Khan I, Kishore A, et al. Pyonephrosis among patients with pyelonephritis admitted in department of nephrology and urology of a tertiary care centre: a descriptive cross-sectional study. JNMA: Journal of the Nepal Medical Association. 2023; 61:111.
20. Shu T, Green JM, Orihuela E. Renal and perirenal abscesses in patients with otherwise anatomically normal urinary tracts. J Urol. 2004; 172:148-50.
21. Bonkat G, Cai T, Veeratterapillay R, et al. Management of Urosepsis in 2018. Eur Urol Focus. 2019; 5:5-9.
22. Capitán Manjón C, Tejido Sánchez A, Piedra Lara JD, et al. Retroperitoneal abscesses--analysis of a series of 66 cases. Scand J Urol Nephrol. 2003; 37:139-44.
23. Xu Z, Xin M, Hong-Zhao L, et al. Retroperitoneoscopic subcapsula nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int. 2004; 94:1329-31.
24. Elkihal N, Senouci K, Hassam B, Ismaili N. (Cutaneous fistula revealing tubercular pyonephrosis). Ann Dermatol Venereol. 2010;137:580-1.
25. Cukier J, Aubert J, Broc A. Pyonephrosis. Study of 50 cases. J Urol Nephrol (Paris). 1971; 77:737-54
Ethics Approval
CRediT authorship contribution
BK: study conception, data collection, manuscript drafting; CMKDY, OJDZ: data analysis and interpretation; OI, AKO: clinical management and data validation; YJRPT, FAK: manuscript revision and supervision; All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.
Data Availability Statement
The datasets used and/or analyzed during the current study are not publicly available due to institutional data protection policies but are available from the corresponding author on reasonable request.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.